Can more be done in obstetric and gynecologic practice to reduce morbidity and mortality associated with venous thromboembolism?

American Journal of Obstetrics and Gynecology

Volumn 180, Issue 4, 1999, Pages 784-791

  Bonnar, John ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; HEPARIN DERIVATIVE; HORMONE; ORAL CONTRACEPTIVE AGENT; PROTEIN C; PROTEIN S;

CLINICAL FEATURE; CLINICAL PRACTICE; CONFERENCE PAPER; EPIDURAL ANESTHESIA; FEMALE; HORMONE SUBSTITUTION; HUMAN; MATERNAL MORBIDITY; MATERNAL MORTALITY; ORAL CONTRACEPTION; PERIOPERATIVE PERIOD; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; RESEARCH; RISK ASSESSMENT; RISK FACTOR; SPINAL ANESTHESIA; THROMBOEMBOLISM; THROMBOGENESIS; THROMBOPHILIA; VEIN THROMBOSIS;

EID: 0032901312     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70648-4     Document Type: Conference Paper

References (36)

1. 1. Kelly HA, Burrage W. American medical biographies. Baltimore: 1920.
2. 2. Lansing DL. Joseph Price, MD, LLD (Hon) (1853-1911): the American Tait. J Pelvic Surg 1996;2:225-8.
3. 3. Hibbard BM, Anderson MM, Drife JO, et al. Report on confidential enquiries into maternal deaths in the United Kingdom 1991-93. London: Her Majesty's Stationery Office; 1996.
4. 4. McColl MD, Ramsay JE, Tait RC, et al. Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost. 1997;74:1183-8.
5. 5. Toglia MR, Nolan TE. Venous thromboembolism during pregnancy: a current review of diagnosis and management. Obstet Gynecol Surv 1996;52:60-72.
6. 6. Lindhagen A, Berqvist A, Berqvist D, Hallbrook T. Late venous function in the leg after deep venous thrombosis occurring in relation to pregnancy. Br J Obstet Gynaecol 1986;93:348-52.
7. 7. Bonnar J, McNicol GP, Douglas AS. The blood coagulation and librinolytic systems in the newborn and the mother at birth. J Obstet Gynaecol Br Commonw 1971;78:355-60.
8. 8. Molloy AM, Daly S, Mills JL, Kirke PN, Whitehead AS, Ramsbottom D, et al. Thermolabile variant of 5, 10-methylenetetrahydrafolate reductase associated with low red cell folates: implications for folate intake recommendations. Lancet 1997;349:1591-3.
9. 9. Faught W, Garner PJ, Jones G, Ivey B. Changes in prolein C and protein S levels in normal pregnancy. Am J Obstet Gynecol 1995;72:147-50.
10. 10. Lefkowitz JB, Clarke SH, Barbour LA. Comparison of protein S functional and antigenic assays in normal pregnancy. Am J Obstet Gynecol 1996;175:657-60.
11. 11. Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4,047 men and women: implications for venous thromboembolism screening. JAMA 1997;277: 1305-7.
12. 12. Walker MC, Garner PR, Keely EJ, Rock GA, Reis MD. Changes in activator protein C resistance during normal pregnancy. Am J Obstet Gynecol 1997;177:162-9.
13. 13. Girling J, de Swiet M. Inherited thrombophilia and pregnancy. Curr Opin Obstet Gynecol 1998;10:135-44.
14. 14. Bonnar J, Norris L, Greene R. Inherited thrombophilia: the obstetric perspective. Semin Hematol 1998;24 Suppl 1:49-53.
15. 15. Preston FE, Rosendaal FR, Walker ID, Briet E, Bemtrop E, Conard J, et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348:913-6.
16. 16. Royal College of Obstetricians and Gynaecologists. Report of the RCOG Working Party on Prophylaxis against Thromboembolism in Gynaecology and Obstetrics 1995. London: The College; 1995
17. 17. Weitz JI. Low molecular weight heparins. N Engl J Med 1997;337:688-98.
18. 18. Monreal M, Lafoz E, Olive A, del Rio L, Vedia C. Comparison of subcutaneous unfractionated heparin (Fragmin) in patients with thromboembolism and contraindications to coumarin. Thromb Haemost 1994;71:7-11.
19. 19. Bonnar J, Walsh JJ. Prevention of thrombosis after pelvic surgery by British dextran 70. Lancet 1972;1:614-6.
20. 20. Anonymous. International consensus statement on prevention of venous thromboembolism. Int Angiol 1997;16:3-38.
21. 21. Walsh JJ, Bonnar J, Wright FW. A study of pulmonary embolism and deep leg vein thrombosis after major gynaecological surgery using labelled fibrinogen, phlebography and lung scanning. J Obstet Gynaec Br Commonw 1974;81:311-6.
22. 22. Bonnar J. Venous thromboembolism and gynaecologic surgery. Clin Obstet Gynecol 1985;28:432-46.
23. 23. Clarke-Pearson DL, Coleman RE, Synan IS, Hinshaw W, Creasman WT. Venous thromboembolism prophylaxis in gynecologic oncology: a prospective controlled trial of low dose heparin. Am J Obstet Gynecol 1983;145:606-13.
24. 24. Clarke-Pearson DL, Synan IS, Hinshaw W, Coleman RE, Creasman WT. Prevention of post-operative venous thromboembolism by external pneumatic calf compression in patients with gynecologic malignancy. Obstet Gynecol 1984;63:92-8.
25. 25. Clarke-Pearson DL, DeLong E, Synan IS, Soper JT, Creasman WT, Coleman RE. A controlled trial of two low dose heparin regimens for the prevention of postoperative deep vein thrombosis. Obstet Gynecol 1990;75:684-9.
26. 26. Campling EA, Devlin HB, Hoile RW, Lunn JN. Report of the national confidential enquiry into perioperative deaths 1989. London: Nuffield Provincial Hospitals Trust and the King's Fund; 1990.
27. 27. Sharpe VA, Faden AI. Medical harm. New York: Cambridge University Press; 1908.
28. 28. Campling EA, Devlin HB, Hoile RW, Lunn JN. Report of the national confidential enquiry into perioperative deaths 1991/92. London: 1993.
29. 29. Campling EA, Devlin HB, Hoile RW, Lunn JN. Report of the national confidential enquiry into perioperative deaths 1992/93. London: 1995.
30. 30. Gallimore SG, Hoile RW, Ingram GS, Sherry KM. Report of the national confidential enquiry into perioperative deaths 1994/1995. London: 1997.
31. 31. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administrative of subcutaneous heparin: overview of results of randomized trials in general orthopedic and urologic surgery. N Engl J Med 1988;318:1162-73.
32. 32. Food and Drug Administration. Reports of epidural or spinal hematomas with the concurrent use of low molecular weight heparin and spinal/epidural anaesthesia or spinal puncture. Washington: The Administration; 1997 Dec.
33. 33. Vessey M, Mant D, Smith A, Yeates D. Oral contraceptives and venous thromboembolism: findings in a large prospective study. BMJ 1986;292:526.
34. 34. Daly E, Vessey MP, Hawkins MM, Carson JL, Gough P, Marsh S. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996;348:981-3.
35. 35. Jick H, Derby LE, Myers MW, Vasilakis C, Newtov K. The risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. Lancet 1996; 348:981-3.
36. 36. Grodstein F, Stampfer MJ, Goldhaber Z, Manson JE, Colditz GA, Speizer FE, et al. Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet 1996;348:983-7.